The SABRE Trial of Hypertonic Saline in Acute Bronchiolitis

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
Acute Bronchiolitis
Interventions
DEVICE

3% hypertonic saline

4 ml dose to be administered every 6 hours

Trial Locations (9)

L12 2AP

Alder Hey Children's NHS Foundation Trust Hospital, Liverpool

ST4 6QG

University Hospital of North Staffordshire, Stoke

CF14 4XW

University Hospital of Wales, Cardiff

DN2 5LT

Doncaster & Bassetlaw Hospitals NHS Foundation Trust, Doncaster

S60 2UD

Rotherham NHS Foundation Trust, Rotherham

S10 2TH

Sheffield Children's NHS Foundation Trust, Sheffield

BD9 6RJ

Bradford Teaching Hospitals NHS Foundation Trust, Bradford

Unknown

Calderdale and Huddersfield NHS Foundation Trust, Halifax

LS1 3EX

Leeds Teaching Hospital NHS Trust, Leeds

All Listed Sponsors
collaborator

University of Sheffield

OTHER

lead

Sheffield Children's NHS Foundation Trust

OTHER

NCT01469845 - The SABRE Trial of Hypertonic Saline in Acute Bronchiolitis | Biotech Hunter | Biotech Hunter